Carnitine Increases Glucose Disposal in Humans
Andrea De Gaetano, MD, PhD (Math),
Geltrude Mingrone, MD, PhD, FACN,
Marco Castagneto, MD, FACS and
Menotti Calvani, MD, PhD,
Consiglio Nazionale delle Ricerche, Centro Fisiopatologia Shock, Laboratorio di Biomatematica (A.D.G., M.C.), Rome, ITALY
Istituto di Clinica Medica, Universita' Cattolica del Sacro Cuore (G.M., M.C.), Rome, ITALY
View larger version (18K):
[in a new window]
|
Fig. 1. Time/concentration data points and fitted model curves for blood glucose in experimental subject #9. Lines are predicted concentrations; points are observed values.
|
|
View larger version (16K):
[in a new window]
|
Fig. 2. Time/concentration data points and fitted model curves for blood insulin in experimental subject #9.
|
|
View larger version (16K):
[in a new window]
|
Fig. 3. Time/concentration data points and fitted model curves for blood C-peptide in experimental subject #9.
|
|
View larger version (62K):
[in a new window]
|
Fig. 4. Group averages and standard errors (I-bars) for RQ during successive time periods. Shaded: placebo; hollow: carnitine. Significant differences between placebo and carnitine at (0–30') and at (30–60').
|
|
View larger version (64K):
[in a new window]
|
Fig. 5. Group averages and standard errors (I-bars) for EE during successive time periods. Shaded: placebo; hollow: carnitine. No significant differences between placebo and carnitine.
|
|
View larger version (31K):
[in a new window]
|
Fig. 6. Group averages and standard errors (I-bars) for NEFA (as % of baseline level) during successive time periods. Shaded: placebo; hollow: carnitine. Significant differences between placebo and carnitine at 6', 25' and 100'.
|
|
Copyright © 1999 by the American College of Nutrition.
